In September 2020, during the peak of the COVID-19 pandemic, Ilene Klein, MD, noticed she was experiencing transient fatigue and a general sense of being out of shape. As a physician, Klein recognized that this fatigue wasn’t due to lack of sleep. Additionally, her resting heart rate, usually in the upper 40s or lower 50s, unexpectedly rose to the low 70s. Despite increasing her walking regimen to improve her condition, she found no relief and decided to seek medical attention.
In January 2021, she was diagnosed with a rare type of lymphoma called T-cell histiocyte-rich B-cell lymphoma, which had reached Stage 4. Accounting for approximately 1 percent of B-cell lymphomas and typically occurring in men, this subtype lacks a specific treatment protocol and is managed like a large B-cell lymphoma with R-CHOP, a combination drug treatment.
Klein was enrolled in a clinical trial at UC San Diego Health, which is a research study conducted to evaluate the safety and effectiveness of medical interventions, such as drugs, medical devices or treatments, in humans. These trials are essential for developing new treatments and improving existing ones.
"Once I was under the care of my #oncologist, supported by a dedicated team, family, friends, colleagues and resources like the The Leukemia & Lymphoma Society, my experience surpassed expectations," said Klein. "Despite the challenging diagnosis, I tolerated treatment well, and the collective support I enjoyed played a pivotal role in helping me maintain a generally positive outlook."
Klein just celebrated her 3-year post-chemo milestone of no detectable disease.
"The day I received my PET/CT report indicating there was no detectable disease was nothing short of miraculous. Thoroughly reviewing the report with my oncologist and radiologist provided much-needed reassurance," said Klein.
Klein reflects on her journey and gives advice to anyone who may be feeling “off” or have questions and concerns about their treatment.
"Cancer is not the time to be silent; it’s a crucial time to speak openly, ask questions – big and small, express your concerns and voice your needs to your doctor and care team. Remember, when confronted with cancer, your voice is an invaluable instrument in your wellbeing," she said.
Klein also expressed her gratitude for the exceptional care she received at UC San Diego Health and the opportunity to participate in a clinical trial.
"Each time I visit the growing and inspiring UC San Diego Health medical center campus, I am reminded of my deep gratitude for the exceptional care that saved my life, while also representing the prospect of life-saving discoveries in years to come," Klein said.
Learn more about cancer care at UC San Diego Health: https://lnkd.in/gVTpBeYr
